Chronic medical conditions and late effects following non‐Hodgkin lymphoma in HIV‐uninfected and HIV‐infected adolescents and young adults: a population‐based study

2020 ◽  
Vol 190 (3) ◽  
pp. 371-384 ◽  
Author(s):  
Renata Abrahão ◽  
Qian W. Li ◽  
Marcio H. Malogolowkin ◽  
Elysia M. Alvarez ◽  
Raul C. Ribeiro ◽  
...  
Keyword(s):  
Young Adults ◽  
Hodgkin Lymphoma ◽  
Late Effects ◽  
Population Based ◽  
Adolescents And Young Adults ◽  
Chronic Medical Conditions ◽  
Medical Conditions ◽  
Population Based Study ◽  
Non Hodgkin Lymphoma

scholarly journals Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population‐based study during 1990–2015

2020 ◽  
Vol 189 (6) ◽  
pp. 1093-1106 ◽  
Author(s):  
Ardine M. J. Reedijk ◽  
Eline A. M. Zijtregtop ◽  
Jan Willem W. Coebergh ◽  
Friederike A. G. Meyer‐Wentrup ◽  
Konnie M. Hebeda ◽  
...  
Keyword(s):  
Young Adults ◽  
The Netherlands ◽  
Hodgkin Lymphoma ◽  
Population Based ◽  
Adolescents And Young Adults ◽  
High Survival ◽  
Population Based Study

scholarly journals Lymphoproliferative malignancies in patients with neurofibromatosis 1

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Christina Bergqvist ◽  
François Hemery ◽  
Arnaud Jannic ◽  
Salah Ferkal ◽  
Pierre Wolkenstein
Keyword(s):  
General Population ◽  
Medical History ◽  
Hodgkin Lymphoma ◽  
Incidence Rate ◽  
Population Based ◽  
Neurofibromatosis 1 ◽  
Population Based Study ◽  
Non Hodgkin Lymphoma ◽  
History Of

AbstractNeurofibromatosis 1 (NF1) is an inherited, autosomal-dominant, tumor predisposition syndrome with a birth incidence as high as 1:2000. A patient with NF1 is four to five times more likely to develop a malignancy as compared to the general population. The number of epidemiologic studies on lymphoproliferative malignancies in patients with NF1 is limited. The aim of this study was to determine the incidence rate of lymphoproliferative malignancies (lymphoma and leukemia) in NF1 patients followed in our referral center for neurofibromatoses. We used the Informatics for Integrated Biology and the Bedside (i2b2) platform to extract information from the hospital’s electronic health records. We performed a keyword search on clinical notes generated between Jan/01/2014 and May/11/2020 for patients aged 18 years or older. A total of 1507 patients with confirmed NF1 patients aged 18 years and above were identified (mean age 39.2 years; 57% women). The total number of person-years in follow-up was 57,736 (men, 24,327 years; women, 33,409 years). Mean length of follow-up was 38.3 years (median, 36 years). A total of 13 patients had a medical history of either lymphoma or leukemia, yielding an overall incidence rate of 22.5 per 100,000 (0.000225, 95% confidence interval (CI) 0.000223–0.000227). This incidence is similar to that of the general population in France (standardized incidence ratio 1.07, 95% CI 0.60–1.79). Four patients had a medical history leukemia and 9 patients had a medical history of lymphoma of which 7 had non-Hodgkin lymphoma, and 2 had Hodgkin lymphoma. Our results show that adults with NF1 do not have an increased tendency to develop lymphoproliferative malignancies, in contrast to the general increased risk of malignancy. While our results are consistent with the recent population-based study in Finland, they are in contrast with the larger population-based study in England whereby NF1 individuals were found to be 3 times more likely to develop both non-Hodgkin lymphoma and lymphocytic leukemia. Large-scale epidemiological studies based on nationwide data sets are thus needed to confirm our findings.

scholarly journals Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study

2016 ◽  
Vol 173 (2) ◽  
pp. 292-302 ◽  
Author(s):  
Renata Abrahão ◽  
Ruth H. Keogh ◽  
Daphne Y. Lichtensztajn ◽  
Rafael Marcos-Gragera ◽  
Bruno C. Medeiros ◽  
...  
Keyword(s):  
Young Adults ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Early Death ◽  
Population Based ◽  
Adolescents And Young Adults ◽  
Population Based Study ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document